Interest: A consulting firm for small businesses matches clients with a team of consultants to answer marketing questions through a technique called crowdsourcing.
Interest: The fund will be used "primarily to boost the institute's ongoing research in wound healing." BioInnovation Institute President and Chief Executive Dr. Frank Douglas said, "This has tremendous applications to the war efforts. Many of our soldiers die in the field because of wounds."
Interest: "The Arizona Center for Innovation provides structured business development for new technology companies. It works with UA students and faculty and staff members in moving technology through the commercialization process to create new companies in Southern Arizona as well as entrepreneurs from the community."
Interest: PARTEQ, one of the biggest university-based technology transfer organizations in Canada, is poised to take advantage of the economic recovery to commercialize "a lot of intellectual property that has a great deal of value.”
Interest: "A new state law will advance establishment of technology commercialization clinics at universities throughout New York based on a model developed at the Syracuse University (SU) College of Law."
Interest: Sandra Miller, Kauffman Foundation director of Advancing Innovation said, "The Postdoctoral awards foster entrepreneurship in the scientific community by recognizing scholars who are taking steps to bring their innovations to market. That's important because commercialization is the key to ensuring that research realizes the good it is meant to achieve."
Interest: “There are absolutely [university invented] drug candidates that are commercializable,” said Jay Schrankler, director of the Office for Technology Commercialization (OTC). “We need to start a big [initiative] so we have more opportunity to get drugs to the market.”
Interest: “It will strengthen America’s position in the power — particularly wind power — industry and keep us toward our goal of being energy independent,” Texas Gov. Rick Perry said.
Interest: The state of Connecticut’s $100M initiative in stem cell research has resulted in a development of a “technique that converts human embryonic stem cells into cartilage cells,” which could be a cure to osteoarthritis.
Interest: With an entrepreneurial president at the helm, the University of Massachusetts continues to expand, using funds from an ever increasing enrollment as well as other non-state resources, including research commercialization, despite a decrease in state funding.
Interest: Universities not only see commercialized invention as a source of income, but also as a way to "attract faculty talent, increase prestige and impact society."
Interest: “Most of our companies here fall into the $2 million to $3 million range,” and that’s too small for many venture capitalists and too big for many angel investors, said NTEC senior director Hubert Zajicek.
Interest: Professor Caroline Dealy "is working on a way to create cartilage cells, with a start-up company formed to help turn the research into a potential therapy and an eye toward one day helping millions of people with osteoarthritis."
Interest: Crooked Monkey is set to launch a new high-end line named, "Blueprint", targeting retailers like Saks, Bloomingdale's, Neiman Marcus and others. Company owners are concerned about launching a high-end line in the present economic climate.
Interest: RXi Pharmaceuticals Corp. wins $300,000 grant funded by the National Institute of Allergy and Infectious Diseases (NIAID) to “support the company’s pre-clinical development of RNAi therapeutics.”
Interest: “As many as 10 local start-up companies could soon be doing business in leased office space with access to services” at the Bowie Business Innovation Center at Bowie State University, to be funded by the city.
Interest: Three ventures that have social and environmental leanings have been "selected to receive space, financial support, and mentoring" from the New Economy Venture Accelerator.
Loading...